AIM: To determine whether specialist oncological radiology review of outside cross-sectional imaging affects patient management. MATERIALS AND METHODS: Five hundred and twenty-six patients attending a regional oncology centre had review of outside cross-sectional imaging over a 1-year period. The number of examinations per patient, time interval between examination and review request, and examination technical adequacy were recorded in each case. More detailed evaluation of 124 patients included comparison of outside and review reports for major differences in interpretation by a medical oncologist who also evaluated the effect of the review on patient management. Examinations resulting in major report discrepancies were subjected to independent radiological adjudication. RESULTS: Eighty-one percent of examinations were reviewed within 3 months of being performed and 94% were considered technically adequate. The hard copy images provided were incomplete in 33% of cases and a calibration rule was absent in 9%. There was a major difference in interpretation in 34% of examinations, the most common cause being differences in interpretation of lymphadenopathy (52%), particularly in the mediastinum (19%). Other problems identified were the failure to record disease dimensions and absence of specific information on key organs in the outside reports. Specialist radiology review changed radiological staging in 19% of patients, affected management in 7% of patients and resulted in a change in treatment in 4%. There was no correlation between management change and any particular tumour type. In 27% of cases, treatment decisions had been made before the review was requested. CONCLUSION: Specialist oncological radiology review of outside cross-sectional imaging changed radiological staging in 19% of cases but had little impact on patient management. Oncological cross-sectional imaging techniques in the North West of England are of high quality, probably helped by recent RCR guidelines.
AIM: To determine whether specialist oncological radiology review of outside cross-sectional imaging affects patient management. MATERIALS AND METHODS: Five hundred and twenty-six patients attending a regional oncology centre had review of outside cross-sectional imaging over a 1-year period. The number of examinations per patient, time interval between examination and review request, and examination technical adequacy were recorded in each case. More detailed evaluation of 124 patients included comparison of outside and review reports for major differences in interpretation by a medical oncologist who also evaluated the effect of the review on patient management. Examinations resulting in major report discrepancies were subjected to independent radiological adjudication. RESULTS: Eighty-one percent of examinations were reviewed within 3 months of being performed and 94% were considered technically adequate. The hard copy images provided were incomplete in 33% of cases and a calibration rule was absent in 9%. There was a major difference in interpretation in 34% of examinations, the most common cause being differences in interpretation of lymphadenopathy (52%), particularly in the mediastinum (19%). Other problems identified were the failure to record disease dimensions and absence of specific information on key organs in the outside reports. Specialist radiology review changed radiological staging in 19% of patients, affected management in 7% of patients and resulted in a change in treatment in 4%. There was no correlation between management change and any particular tumour type. In 27% of cases, treatment decisions had been made before the review was requested. CONCLUSION: Specialist oncological radiology review of outside cross-sectional imaging changed radiological staging in 19% of cases but had little impact on patient management. Oncological cross-sectional imaging techniques in the North West of England are of high quality, probably helped by recent RCR guidelines.
Authors: J Kriz; C Bangard; U Haverkamp; R Bongartz; C Baues; A Engert; R-P Mueller; H T Eich Journal: Strahlenther Onkol Date: 2012-06-14 Impact factor: 3.621
Authors: Aleksandr Rozenberg; Barry E Kenneally; John A Abraham; Kristin Strogus; Johannes B Roedl; William B Morrison; Adam C Zoga Journal: Skeletal Radiol Date: 2018-07-12 Impact factor: 2.199
Authors: Vaios Hatzoglou; Antonio M Omuro; Sofia Haque; Yasmin Khakoo; Ian Ganly; Jung Hun Oh; Amita Shukla-Dave; Robin Fatovic; Joshua Gaal; Andrei I Holodny Journal: Cancer Date: 2016-05-24 Impact factor: 6.860
Authors: Yulia Lakhman; Melvin D'Anastasi; Maura Miccò; Chiara Scelzo; Hebert Alberto Vargas; Stephanie Nougaret; Ramon E Sosa; Dennis S Chi; Nadeem R Abu-Rustum; Hedvig Hricak; Evis Sala Journal: Eur Radiol Date: 2015-10-22 Impact factor: 5.315
Authors: Jacob Sosna; Steven J Esses; Nikolay Yeframov; Hanna Bernstine; Tamar Sella; Shifra Fraifeld; Jonathan B Kruskal; David Groshar Journal: Cancer Imaging Date: 2012-08-10 Impact factor: 3.909
Authors: John T Lysack; Monica Hoy; Mark E Hudon; Steven C Nakoneshny; Shamir P Chandarana; T Wayne Matthews; Joseph C Dort Journal: J Otolaryngol Head Neck Surg Date: 2013-06-05